L. J. Bonfiglio

A Phase III, Double-blind, Placebo-controlled, Multicenter Study on the Efficacy of Recombinant Human Antithrombin in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

J. Scholz, P. Rosseel, D. Kajdasz, 2005, Anesthesiology.

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations

R. Tait, S. Schulman, A. Mumford, 2008, Thrombosis and Haemostasis.

Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.

D. Kajdasz, R. Feneck, G. Despotis, 2005, The Journal of thoracic and cardiovascular surgery.